Lifeboat Foundation

Hypothetical interstellar civilizations could employ such signals for lossless long-distance communication.

Swave Photonics has designed holographic chips on a proprietary diffractive optics technology to “bring the metaverse to life.”

Can virtual reality become indistinguishable from actual reality? Swave Photonics, a spinoff of Imec and Vrije Universiteit Brussel, has designed holographic chips on a proprietary diffractive optics technology to “bring the metaverse to life.” The Leuven, Belgium–based startup has raised €7 million in seed funding to accelerate the development of its multi-patented Holographic eXtended Reality (HXR) technology.

“Our vision is to empower people to visualize the impossible, collaborate, and accomplish more,” Théodore Marescaux, CEO and founder of Swave Photonics, told EE Times Europe. “With our HXR technology, we want to make that extended reality practically indistinguishable from the real world.”

Continue reading “Swave Photonics Sees Holograms Getting Real” »

Thorough evaluation of CRISPR RNA-guided nucleases off-targets in cells is required for advancing gene therapies. Here the authors report SURRO-seq for the simultaneous investigation of thousands of off-target sites for therapeutic RNA-guided nucleases in cells.

A new technique to measure vibrating atoms could improve the precision of atomic clocks and of quantum sensors for detecting dark matter or gravitational waves.

Gravitational waves are distortions or ripples in the fabric of space and time. They were first detected in 2015 by the Advanced LIGO detectors and are produced by catastrophic events such as colliding black holes, supernovae, or merging neutron stars.

So precise.

If chemists built cars, they’d fill a factory with car parts, set it on fire, and sift from the ashes pieces that now looked vaguely car-like.

When you’re dealing with car-parts the size of atoms, this is a perfectly reasonable process. Yet chemists yearn for ways to reduce the waste and make reactions far more precise.

Continue reading “Chemists Just Rearranged Atomic Bonds in a Single Molecule For The First Time” »

Up until recently, almost all pediatric liver cancers were classified as either hepatoblastoma or hepatocellular carcinoma. However, pediatric pathologists have noted that certain liver tumors have histological characteristics that do not readily match either of these two carcinoma models. The outcomes for patients with these tumors are poor and the tumors are less likely to respond to chemotherapy.

Dr. Pavel Sumazin, an associate professor of pediatrics at Texas Children’s Cancer and Hematology Center and Baylor College of Medicine, sought to better understand this high-risk cancer.